X

Alkem Laboratories Ltd Q1FY25; 91% rise in Profits

Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Financial Results:

Alkem Laboratories Ltd reported Revenues for Q1FY25 of ₹3,032.00 Crores up from ₹2,968.00 Crore year on year, a rise of 2.16%.

Total Expenses for Q1FY25 of ₹2,532.00 Crores down from ₹2,681.00 Crores year on year, a fall of 5.56%.

Consolidated Net Profit of ₹550.00 Crores up 90.97% from ₹288.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹45.60, up 90.16% from ₹23.98 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post